See if deep brain stimulation for Parkinson's changes thinking and movement and affects fall risk
Official title: Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation
Run by University of Alabama at Birmingham · NCT07725315 · Data updated 2026-11-12
This pilot study tests whether deep brain stimulation in people with Parkinson’s changes thinking or movement and whether those changes relate to how often they fall.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 80 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Homewood, Alabama) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | November 1, 2027 |
| Study ends | November 1, 2027 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07725315 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 30-80 with Parkinson’s disease who are electing DBS surgery as part of routine care and are able to walk and attend follow-up visits.
✕Probably not a fit
Patients with DBS who are unable to walk or have medical contraindications to surgery may not experience benefit regarding falls or cognitive/motor changes studied.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study investigates cognitive and motor changes after deep brain stimulation (DBS) implantation in Parkinson’s disease patients and explores how these changes may influence fall risk. DBS is used as part of standard care to manage motor symptoms when medication is insufficient. The study aims to identify potential mechanisms contributing to falls and to lay groundwork for interventions that address post-DBS fall risk. It will assess participants over a defined follow-up period to observe changes in axial motor symptoms, balance, and related factors. The approach focuses on causal factors rather than comparing DBS to other treatments.
Why it matters
Potential benefit: If successful, the study could help clinicians tailor DBS management to reduce fall risk and improve quality of life for people with Parkinson’s disease.
How similar studies have gone: Prior research on DBS and balance has mixed results; this study addresses a gap by examining causal factors of fall risk after DBS implantation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 30-80, patient has elected to undergo DBS surgery as part of routine care, cleared for deep brain stimulation surgery as part of routine care by the movement disorders committee. Refractory motor symptoms such as dyskinesias, wearing off, and/or motor fluctuations, causing significant disability, despite reasonable attempts at medical management, as determined by the consensus DBS committee, able to walk, Patient is available for follow-up over the length of the study Exclusion Criteria: Patient's insurance will not cover the costs of surgery with investigational devices, Medical contraindications such as current uncontrolled hypertension, heart disease, coagulopathy, or other conditions contraindicating DBS surgery or stimulation, self-report of lack of clear levodopa response, requires a walker or wheelchair for mobility \-
Where it's running
-
UAB WHARF at Lakeshore
Homewood, Alabama, United States Recruiting
Study contacts
- Study coordinator: Christopher Hurt, PhD
- Email: cphurt@uab.edu
- Phone: 2059345817
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood-based predictors of DBS outcomes for Parkinson's disease
This project will test whether proteins and RNA in blood can predict how people with Parkinson's disease will respond to deep brain stimulation (DBS).
-
UX-DA003 injections for Parkinson's disease
This early-phase trial tests whether injecting UX-DA003 is safe and may help motor symptoms in people with Parkinson's whose response to standard treatments has declined.
-
Strength and dual-task training to help people with Parkinson’s improve strength and function
This trial tests three levels of physiotherapy, including progressive resistance training with and without cognitive dual-task and instability components, to see if they improve muscle strength, body composition, and physical function in adults with Parkinson’s or related syndromes.
-
Spinal Mobility, Rigidity, and Kinesiophobia in Parkinson's Disease with and without TMD
This study tests whether people with Parkinson's disease who have Temporomandibular Disorders differ in spinal mobility, axial rigidity, and kinesiophobia from those without TMD.
-
A 12-Week Trial of Flexilev with the OraFID Device and App for Parkinson's
This study tests whether taking small, precise doses of Flexilev with the OraFID dosing device and Levilog app is acceptable and helps people with Parkinson's manage their medicine.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.